bluuebunny/crossref_metadata_2025 huggingface dataset:
Supplementary Figure 1 from Small interfering RNA library screen of human kinases and phosphatases identifies polo-like kinase 1 as a promising new target for the treatment of pediatric rhabdomyosarcomas
Authors: Hu Kaiji , Lee Cathy , Qiu Dexin , Fotovati Abbas , Davies Alastair , Abu-Ali Samah , Wai Daniel , Lawlor Elizabeth R. , Triche Timothy J. , Pallen Catherine J. , Dunn Sandra E.
Published: April 2023

Supplementary Figure 1 from Small interfering RNA library screen of human kinases and phosphatases identifies polo-like kinase 1 as a promising new target for the treatment of pediatric rhabdomyosarcomas
Supplementary Fig. S3B from Cyclin D3 is down-regulated by rapamycin in HER-2-overexpressing breast cancer cells
Authors: García-Morales Pilar , Hernando Eva , Carrasco-García Estefanía , Menéndez-Gutierrez María Piedad , Saceda Miguel , Martínez-Lacaci Isabel
Published: April 2023

Supplementary Fig. S3B from Cyclin D3 is down-regulated by rapamycin in HER-2-overexpressing breast cancer cells
Supplementary Fig. S3A from Cyclin D3 is down-regulated by rapamycin in HER-2-overexpressing breast cancer cells
Authors: García-Morales Pilar , Hernando Eva , Carrasco-García Estefanía , Menéndez-Gutierrez María Piedad , Saceda Miguel , Martínez-Lacaci Isabel
Published: April 2023

Supplementary Fig. S3A from Cyclin D3 is down-regulated by rapamycin in HER-2-overexpressing breast cancer cells
Supplementary Figures 1-6 from Characterization of novel inhibitors of histone acetyltransferases
Authors: Eliseeva Elena D. , Valkov Vassil , Jung Manfred , Jung Mira O.
Published: April 2023

Supplementary Figures 1-6 from Characterization of novel inhibitors of histone acetyltransferases
Supplementary Figure 1 from H2AX phosphorylation marks gemcitabine-induced stalled replication forks and their collapse upon S-phase checkpoint abrogation
Authors: Ewald Brett , Sampath Deepa , Plunkett William
Published: April 2023

Supplementary Figure 1 from H2AX phosphorylation marks gemcitabine-induced stalled replication forks and their collapse upon S-phase checkpoint abrogation
Supplementary Tables S1-S2 from Reduced Argininosuccinate Synthetase Is a Predictive Biomarker for the Development of Pulmonary Metastasis in Patients with Osteosarcoma
Authors: Kobayashi Eisuke , Masuda Mari , Nakayama Robert , Ichikawa Hitoshi , Satow Reiko , Shitashige Miki , Honda Kazufumi , Yamaguchi Umio , Shoji Ayako , Tochigi Naobumi , Morioka Hideo , Toyama Yoshiaki , Hirohashi Setsuo , Kawai Akira , Yamada Tesshi
Published: April 2023

Supplementary Tables S1-S2 from Reduced Argininosuccinate Synthetase Is a Predictive Biomarker for the Development of Pulmonary Metastasis in Patients with Osteosarcoma
Supplementary Fig. S3 from Interruption of RNA processing machinery by a small compound, 1-[(4-chlorophenyl)methyl]-1H-indole-3-carboxaldehyde (oncrasin-1)
Authors: Guo Wei , Wu Shuhong , Wang Li , Wang Rui-yu , Wei Xiaoli , Liu Jinsong , Fang Bingliang
Published: April 2023

Supplementary Fig. S3 from Interruption of RNA processing machinery by a small compound, 1-[(4-chlorophenyl)methyl]-1H-indole-3-carboxaldehyde (oncrasin-1)
Supplementary Tables S1 & S2 from Reduced Argininosuccinate Synthetase Is a Predictive Biomarker for the Development of Pulmonary Metastasis in Patients with Osteosarcoma
Authors: Kobayashi Eisuke , Masuda Mari , Nakayama Robert , Ichikawa Hitoshi , Satow Reiko , Shitashige Miki , Honda Kazufumi , Yamaguchi Umio , Shoji Ayako , Tochigi Naobumi , Morioka Hideo , Toyama Yoshiaki , Hirohashi Setsuo , Kawai Akira , Yamada Tesshi
Published: April 2023

Supplementary Tables S1 & S2 from Reduced Argininosuccinate Synthetase Is a Predictive Biomarker for the Development of Pulmonary Metastasis in Patients with Osteosarcoma
Supplementary Fig. S2 from Interruption of RNA processing machinery by a small compound, 1-[(4-chlorophenyl)methyl]-1H-indole-3-carboxaldehyde (oncrasin-1)
Authors: Guo Wei , Wu Shuhong , Wang Li , Wang Rui-yu , Wei Xiaoli , Liu Jinsong , Fang Bingliang
Published: April 2023

Supplementary Fig. S2 from Interruption of RNA processing machinery by a small compound, 1-[(4-chlorophenyl)methyl]-1H-indole-3-carboxaldehyde (oncrasin-1)
Supplementary Figure Legends from Identification of Predictive Markers of Response to the MEK1/2 Inhibitor Selumetinib (AZD6244) in K-ras–Mutated Colorectal Cancer
Authors: Tentler John J. , Nallapareddy Sujatha , Tan Aik Choon , Spreafico Anna , Pitts Todd M. , Morelli M. Pia , Selby Heather M. , Kachaeva Maria I. , Flanigan Sara A. , Kulikowski Gillian N. , Leong Stephen , Arcaroli John J. , Messersmith Wells A. , Eckhardt S. Gail
Published: April 2023

Supplementary Figure Legends from Identification of Predictive Markers of Response to the MEK1/2 Inhibitor Selumetinib (AZD6244) in K-ras–Mutated Colorectal Cancer
Supplementary Figure 2 from Identification of Predictive Markers of Response to the MEK1/2 Inhibitor Selumetinib (AZD6244) in K-ras–Mutated Colorectal Cancer
Authors: Tentler John J. , Nallapareddy Sujatha , Tan Aik Choon , Spreafico Anna , Pitts Todd M. , Morelli M. Pia , Selby Heather M. , Kachaeva Maria I. , Flanigan Sara A. , Kulikowski Gillian N. , Leong Stephen , Arcaroli John J. , Messersmith Wells A. , Eckhardt S. Gail
Published: April 2023

Supplementary Figure 2 from Identification of Predictive Markers of Response to the MEK1/2 Inhibitor Selumetinib (AZD6244) in K-ras–Mutated Colorectal Cancer
Supplementary Figures from TW-37, a small-molecule inhibitor of Bcl-2, mediates S-phase cell cycle arrest and suppresses head and neck tumor angiogenesis
Authors: Ashimori Naoki , Zeitlin Benjamin D. , Zhang Zhaocheng , Warner Kristy , Turkienicz Ilan M. , Spalding Aaron C. , Teknos Theodoros N. , Wang Shaomeng , Nör Jacques E.
Published: April 2023

Supplementary Figures from TW-37, a small-molecule inhibitor of Bcl-2, mediates S-phase cell cycle arrest and suppresses head and neck tumor angiogenesis
Supplementary Figure 1 from Identification of Predictive Markers of Response to the MEK1/2 Inhibitor Selumetinib (AZD6244) in K-ras–Mutated Colorectal Cancer
Authors: Tentler John J. , Nallapareddy Sujatha , Tan Aik Choon , Spreafico Anna , Pitts Todd M. , Morelli M. Pia , Selby Heather M. , Kachaeva Maria I. , Flanigan Sara A. , Kulikowski Gillian N. , Leong Stephen , Arcaroli John J. , Messersmith Wells A. , Eckhardt S. Gail
Published: April 2023

Supplementary Figure 1 from Identification of Predictive Markers of Response to the MEK1/2 Inhibitor Selumetinib (AZD6244) in K-ras–Mutated Colorectal Cancer
Supplementary Fig. S2 from The antitumoral effect of Paris Saponin I associated with the induction of apoptosis through the mitochondrial pathway
Authors: Xiao Xue , Bai Peng , Bui Nguyen Tri M. , Xiao Jianguo , Liu Shanling , Yang Gong , Hu Lina , Chen Xinlian , Zhang Xuemei , Liu Jinsong , Wang He
Published: April 2023

Supplementary Fig. S2 from The antitumoral effect of Paris Saponin I associated with the induction of apoptosis through the mitochondrial pathway
Supplementary Fig. S1 from The antitumoral effect of Paris Saponin I associated with the induction of apoptosis through the mitochondrial pathway
Authors: Xiao Xue , Bai Peng , Bui Nguyen Tri M. , Xiao Jianguo , Liu Shanling , Yang Gong , Hu Lina , Chen Xinlian , Zhang Xuemei , Liu Jinsong , Wang He
Published: April 2023

Supplementary Fig. S1 from The antitumoral effect of Paris Saponin I associated with the induction of apoptosis through the mitochondrial pathway
Supplementary Table S2 from Inhibition of focal adhesion kinase as a potential therapeutic strategy for imatinib-resistant gastrointestinal stromal tumor
Authors: Sakurama Kazufumi , Noma Kazuhiro , Takaoka Munenori , Tomono Yasuko , Watanabe Nobuyuki , Hatakeyama Shinji , Ohmori Osamu , Hirota Seiichi , Motoki Takayuki , Shirakawa Yasuhiro , Yamatsuji Tomoki , Haisa Minoru , Matsuoka Junji , Tanaka Noriaki , Naomoto Yoshio
Published: April 2023

Supplementary Table S2 from Inhibition of focal adhesion kinase as a potential therapeutic strategy for imatinib-resistant gastrointestinal stromal tumor
Video from Structure-based design of an urokinase-type plasminogen activator receptor–derived peptide inhibiting cell migration and lung metastasis
Authors: Carriero Maria Vincenza , Longanesi-Cattani Immacolata , Bifulco Katia , Maglio Ornella , Lista Liliana , Barbieri Antonio , Votta Giuseppina , Masucci Maria Teresa , Arra Claudio , Franco Renato , De Rosa Mario , Stoppelli Maria Patrizia , Pavone Vincenzo
Published: April 2023

Video from Structure-based design of an urokinase-type plasminogen activator receptor–derived peptide inhibiting cell migration and lung metastasis
Supplementary Table S1 from Inhibition of focal adhesion kinase as a potential therapeutic strategy for imatinib-resistant gastrointestinal stromal tumor
Authors: Sakurama Kazufumi , Noma Kazuhiro , Takaoka Munenori , Tomono Yasuko , Watanabe Nobuyuki , Hatakeyama Shinji , Ohmori Osamu , Hirota Seiichi , Motoki Takayuki , Shirakawa Yasuhiro , Yamatsuji Tomoki , Haisa Minoru , Matsuoka Junji , Tanaka Noriaki , Naomoto Yoshio
Published: April 2023

Supplementary Table S1 from Inhibition of focal adhesion kinase as a potential therapeutic strategy for imatinib-resistant gastrointestinal stromal tumor
Supplementary Data to Figure 3 from Structure-based design of an urokinase-type plasminogen activator receptor–derived peptide inhibiting cell migration and lung metastasis
Authors: Carriero Maria Vincenza , Longanesi-Cattani Immacolata , Bifulco Katia , Maglio Ornella , Lista Liliana , Barbieri Antonio , Votta Giuseppina , Masucci Maria Teresa , Arra Claudio , Franco Renato , De Rosa Mario , Stoppelli Maria Patrizia , Pavone Vincenzo
Published: April 2023

Supplementary Data to Figure 3 from Structure-based design of an urokinase-type plasminogen activator receptor–derived peptide inhibiting cell migration and lung metastasis
Supplementary Figure Legends from CXCR3 expression is associated with poor survival in breast cancer and promotes metastasis in a murine model
Authors: Ma Xinrong , Norsworthy Kelly , Kundu Namita , Rodgers William H. , Gimotty Phyllis A. , Goloubeva Olga , Lipsky Michael , Li Yanchun , Holt Dawn , Fulton Amy
Published: April 2023

Supplementary Figure Legends from CXCR3 expression is associated with poor survival in breast cancer and promotes metastasis in a murine model
Supplementary Figure 2A-D from MUC1 oncoprotein is a druggable target in human prostate cancer cells
Authors: Joshi Maya Datt , Ahmad Rehan , Yin Li , Raina Deepak , Rajabi Hasan , Bubley Glenn , Kharbanda Surender , Kufe Donald
Published: April 2023

Supplementary Figure 2A-D from MUC1 oncoprotein is a druggable target in human prostate cancer cells
Supplementary Figure 1 from MUC1 oncoprotein is a druggable target in human prostate cancer cells
Authors: Joshi Maya Datt , Ahmad Rehan , Yin Li , Raina Deepak , Rajabi Hasan , Bubley Glenn , Kharbanda Surender , Kufe Donald
Published: April 2023

Supplementary Figure 1 from MUC1 oncoprotein is a druggable target in human prostate cancer cells
Supplementary Material from Evaluation of a chemical library of small-molecule Dishevelled antagonists that suppress tumor growth by down-regulating T-cell factor–mediated transcription
Authors: You Liang , Xu Zhidong , Punchihewa Chandanamali , Jablons David M. , Fujii Naoaki
Published: April 2023

Supplementary Material from Evaluation of a chemical library of small-molecule Dishevelled antagonists that suppress tumor growth by down-regulating T-cell factor–mediated transcription
Supplementary Figures from Oncogenic transformation confers a selective susceptibility to the combined suppression of the proteasome and autophagy
Authors: Ding Wen-Xing , Ni Hong-Min , Gao Wentao , Chen Xiaoyun , Kang Jeong Han , Stolz Donna B. , Liu Jinsong , Yin Xiao-Ming
Published: April 2023

Supplementary Figures from Oncogenic transformation confers a selective susceptibility to the combined suppression of the proteasome and autophagy
Supplementary Material from p27Kip1 expression inhibits glioblastoma growth, invasion, and tumor-induced neoangiogenesis
Authors: Schiappacassi Monica , Lovat Francesca , Canzonieri Vincenzo , Belletti Barbara , Berton Stefania , Di Stefano Domenica , Vecchione Andrea , Colombatti Alfonso , Baldassarre Gustavo
Published: April 2023

Supplementary Material from p27Kip1 expression inhibits glioblastoma growth, invasion, and tumor-induced neoangiogenesis
Supplementary Data from Combinations of DNA Methyltransferase and Histone Deacetylase Inhibitors Induce DNA Damage in Small Cell Lung Cancer Cells: Correlation of Resistance with IFN-Stimulated Gene Expression
Authors: Luszczek Wioleta , Cheriyath Venugopalan , Mekhail Tarek M. , Borden Ernest C.
Published: April 2023

Supplementary Data from Combinations of DNA Methyltransferase and Histone Deacetylase Inhibitors Induce DNA Damage in Small Cell Lung Cancer Cells: Correlation of Resistance with IFN-Stimulated Gene Expression
Supplemental Table S4 from Activity of PXD101, a histone deacetylase inhibitor, in preclinical ovarian cancer studies
Authors: Qian Xiaozhong , LaRochelle William J. , Ara Gulshan , Wu Frank , Petersen Kamille Dumong , Thougaard Annemette , Sehested Maxwell , Lichenstein Henri S. , Jeffers Michael
Published: April 2023

Supplemental Table S4 from Activity of PXD101, a histone deacetylase inhibitor, in preclinical ovarian cancer studies
Supplemental Table S3 from Activity of PXD101, a histone deacetylase inhibitor, in preclinical ovarian cancer studies
Authors: Qian Xiaozhong , LaRochelle William J. , Ara Gulshan , Wu Frank , Petersen Kamille Dumong , Thougaard Annemette , Sehested Maxwell , Lichenstein Henri S. , Jeffers Michael
Published: April 2023

Supplemental Table S3 from Activity of PXD101, a histone deacetylase inhibitor, in preclinical ovarian cancer studies
Supplementary Data from Microtubule Dynamics, Mitotic Arrest, and Apoptosis: Drug-Induced Differential Effects of βIII-Tubulin
Authors: Gan Pei Pei , McCarroll Joshua A. , Po'uha Sela T. , Kamath Kathy , Jordan Mary Ann , Kavallaris Maria
Published: April 2023

Supplementary Data from Microtubule Dynamics, Mitotic Arrest, and Apoptosis: Drug-Induced Differential Effects of βIII-Tubulin
Supplemental Table S2 from Activity of PXD101, a histone deacetylase inhibitor, in preclinical ovarian cancer studies
Authors: Qian Xiaozhong , LaRochelle William J. , Ara Gulshan , Wu Frank , Petersen Kamille Dumong , Thougaard Annemette , Sehested Maxwell , Lichenstein Henri S. , Jeffers Michael
Published: April 2023

Supplemental Table S2 from Activity of PXD101, a histone deacetylase inhibitor, in preclinical ovarian cancer studies
Supplementary Figure Legends 1-2, Table from Experimental cancer therapy using restoration of NAD+-linked 15-hydroxyprostaglandin dehydrogenase expression
Authors: Kaliberova Lyudmila N. , Kusmartsev Sergei A. , Krendelchtchikova Valentina , Stockard Cecil R. , Grizzle William E. , Buchsbaum Donald J. , Kaliberov Sergey A.
Published: April 2023

Supplementary Figure Legends 1-2, Table from Experimental cancer therapy using restoration of NAD+-linked 15-hydroxyprostaglandin dehydrogenase expression
Supplementary Figure 2 from Experimental cancer therapy using restoration of NAD+-linked 15-hydroxyprostaglandin dehydrogenase expression
Authors: Kaliberova Lyudmila N. , Kusmartsev Sergei A. , Krendelchtchikova Valentina , Stockard Cecil R. , Grizzle William E. , Buchsbaum Donald J. , Kaliberov Sergey A.
Published: April 2023

Supplementary Figure 2 from Experimental cancer therapy using restoration of NAD+-linked 15-hydroxyprostaglandin dehydrogenase expression
Supplementary Data from The Use of One-Bead One-Compound Combinatorial Library Technology to Discover High-Affinity αvβ3 Integrin and Cancer Targeting Arginine-Glycine-Aspartic Acid Ligands with a Built-in Handle
Authors: Xiao Wenwu , Wang Yan , Lau Edmond Y. , Luo Juntao , Yao Nianhuan , Shi Changying , Meza Leah , Tseng Harry , Maeda Yoshiko , Kumaresan Pappanaicken , Liu Ruiwu , Lightstone Felice C. , Takada Yoshikazu , Lam Kit S.
Published: April 2023

Supplementary Data from The Use of One-Bead One-Compound Combinatorial Library Technology to Discover High-Affinity αvβ3 Integrin and Cancer Targeting Arginine-Glycine-Aspartic Acid Ligands with a Built-in Handle
Supplementary Materials from Folate-mediated intracellular drug delivery increases the anticancer efficacy of nanoparticulate formulation of arsenic trioxide
Authors: Chen Haimei , Ahn Richard , Van den Bossche Jeroen , Thompson David H. , O'Halloran Thomas V.
Published: April 2023

Supplementary Materials from Folate-mediated intracellular drug delivery increases the anticancer efficacy of nanoparticulate formulation of arsenic trioxide
Supplementary Table 3 from Abcc2 (Mrp2), Abcc3 (Mrp3), and Abcg2 (Bcrp1) are the main determinants for rapid elimination of methotrexate and its toxic metabolite 7-hydroxymethotrexate in vivo
Authors: Vlaming Maria L. H. , van Esch Anita , Pala Zeliha , Wagenaar Els , van de Wetering Koen , van Tellingen Olaf , Schinkel Alfred H.
Published: April 2023

Supplementary Table 3 from Abcc2 (Mrp2), Abcc3 (Mrp3), and Abcg2 (Bcrp1) are the main determinants for rapid elimination of methotrexate and its toxic metabolite 7-hydroxymethotrexate in vivo
Supplementary Fig. S4 from Chk1 and Chk2 are differentially involved in homologous recombination repair and cell cycle arrest in response to DNA double-strand breaks induced by camptothecins
Authors: Huang Min , Miao Ze-Hong , Zhu Hong , Cai Yu-Jun , Lu Wei , Ding Jian
Published: April 2023

Supplementary Fig. S4 from Chk1 and Chk2 are differentially involved in homologous recombination repair and cell cycle arrest in response to DNA double-strand breaks induced by camptothecins
Supplementary Figure Legend from Abcc2 (Mrp2), Abcc3 (Mrp3), and Abcg2 (Bcrp1) are the main determinants for rapid elimination of methotrexate and its toxic metabolite 7-hydroxymethotrexate in vivo
Authors: Vlaming Maria L. H. , van Esch Anita , Pala Zeliha , Wagenaar Els , van de Wetering Koen , van Tellingen Olaf , Schinkel Alfred H.
Published: April 2023

Supplementary Figure Legend from Abcc2 (Mrp2), Abcc3 (Mrp3), and Abcg2 (Bcrp1) are the main determinants for rapid elimination of methotrexate and its toxic metabolite 7-hydroxymethotrexate in vivo
Supplementary Fig. S3 from Chk1 and Chk2 are differentially involved in homologous recombination repair and cell cycle arrest in response to DNA double-strand breaks induced by camptothecins
Authors: Huang Min , Miao Ze-Hong , Zhu Hong , Cai Yu-Jun , Lu Wei , Ding Jian
Published: April 2023

Supplementary Fig. S3 from Chk1 and Chk2 are differentially involved in homologous recombination repair and cell cycle arrest in response to DNA double-strand breaks induced by camptothecins
Supplementary Fig. S1 from Chk1 and Chk2 are differentially involved in homologous recombination repair and cell cycle arrest in response to DNA double-strand breaks induced by camptothecins
Authors: Huang Min , Miao Ze-Hong , Zhu Hong , Cai Yu-Jun , Lu Wei , Ding Jian
Published: April 2023

Supplementary Fig. S1 from Chk1 and Chk2 are differentially involved in homologous recombination repair and cell cycle arrest in response to DNA double-strand breaks induced by camptothecins
Supplementary Fig Legends from Chk1 and Chk2 are differentially involved in homologous recombination repair and cell cycle arrest in response to DNA double-strand breaks induced by camptothecins
Authors: Huang Min , Miao Ze-Hong , Zhu Hong , Cai Yu-Jun , Lu Wei , Ding Jian
Published: April 2023

Supplementary Fig Legends from Chk1 and Chk2 are differentially involved in homologous recombination repair and cell cycle arrest in response to DNA double-strand breaks induced by camptothecins
Supplementary Data from Blockade of Rac1 Activity Induces G1 Cell Cycle Arrest or Apoptosis in Breast Cancer Cells through Downregulation of Cyclin D1, Survivin, and X-Linked Inhibitor of Apoptosis Protein
Authors: Yoshida Tatsushi , Zhang Yaqin , Rivera Rosado Leslie A. , Chen Junjie , Khan Tahira , Moon Sun Young , Zhang Baolin
Published: April 2023

Supplementary Data from Blockade of Rac1 Activity Induces G1 Cell Cycle Arrest or Apoptosis in Breast Cancer Cells through Downregulation of Cyclin D1, Survivin, and X-Linked Inhibitor of Apoptosis Protein
Supplementary Table 1 from Molecular Evolutionary Analysis of Cancer Cell Lines
Authors: Zhang Yan , Italia Michael J. , Auger Kurt R. , Halsey Wendy S. , Van Horn Stephanie F. , Sathe Ganesh M. , Magid-Slav Michal , Brown James R. , Holbrook Joanna D.
Published: April 2023

Supplementary Table 1 from Molecular Evolutionary Analysis of Cancer Cell Lines
Supplementary Figure 1 from Subcellular Distribution of a Fluorescence-Labeled Combi-Molecule Designed to Block Epidermal Growth Factor Receptor Tyrosine Kinase and Damage DNA with a Green Fluorescent Species
Authors: Todorova Margarita I. , Larroque Anne-Laure , Dauphin-Pierre Sabine , Fang You-Qiang , Jean-Claude Bertrand J.
Published: April 2023

Supplementary Figure 1 from Subcellular Distribution of a Fluorescence-Labeled Combi-Molecule Designed to Block Epidermal Growth Factor Receptor Tyrosine Kinase and Damage DNA with a Green Fluorescent Species
Supplementary Figure 2 from Molecular Evolutionary Analysis of Cancer Cell Lines
Authors: Zhang Yan , Italia Michael J. , Auger Kurt R. , Halsey Wendy S. , Van Horn Stephanie F. , Sathe Ganesh M. , Magid-Slav Michal , Brown James R. , Holbrook Joanna D.
Published: April 2023

Supplementary Figure 2 from Molecular Evolutionary Analysis of Cancer Cell Lines
Supplementary Figure 1 from SIRT Inhibitors Induce Cell Death and p53 Acetylation through Targeting Both SIRT1 and SIRT2
Authors: Peck Barrie , Chen Chun-Yuan , Ho Ka-Kei , Di Fruscia Paolo , Myatt Stephen S. , Coombes R. Charles , Fuchter Matthew J. , Hsiao Chwan-Deng , Lam Eric W.-F.
Published: April 2023

Supplementary Figure 1 from SIRT Inhibitors Induce Cell Death and p53 Acetylation through Targeting Both SIRT1 and SIRT2
Supplementary Table S2 from Gene expression profiles do not consistently predict the clinical treatment response in locally advanced breast cancer
Authors: Sørlie Therese , Perou Charles M. , Fan Cheng , Geisler Stephanie , Aas Turid , Nobel Andrew , Anker Gun , Akslen Lars A. , Botstein David , Børresen-Dale Anne-Lise , Lønning Per Eystein
Published: April 2023

Supplementary Table S2 from Gene expression profiles do not consistently predict the clinical treatment response in locally advanced breast cancer
Supplementary Table 2 from Analysis of Food and Drug Administration–Approved Anticancer Agents in the NCI60 Panel of Human Tumor Cell Lines
Authors: Holbeck Susan L. , Collins Jerry M. , Doroshow James H.
Published: April 2023

Supplementary Table 2 from Analysis of Food and Drug Administration–Approved Anticancer Agents in the NCI60 Panel of Human Tumor Cell Lines
Supplementary Fig. S3 from Premature senescence is a major response to DNA cross-linking agents in BRCA1-defective cells: implication for tailored treatments of BRCA1 mutation carriers
Authors: Santarosa Manuela , Del Col Laura , Tonin Elena , Caragnano Angela , Viel Alessandra , Maestro Roberta
Published: April 2023

Supplementary Fig. S3 from Premature senescence is a major response to DNA cross-linking agents in BRCA1-defective cells: implication for tailored treatments of BRCA1 mutation carriers
Supplementary Video from Molecular imaging of Bcr-Abl phosphokinase in a xenograft model
Authors: Wu Ji Yuan , Yang David J. , Angelo Laura S. , Kohanim Saady , Kurzrock Razelle
Published: April 2023

Supplementary Video from Molecular imaging of Bcr-Abl phosphokinase in a xenograft model
Supplementary Data from Inhibition of Fatty Acid Synthase Suppresses c-Met Receptor Kinase and Induces Apoptosis in Diffuse Large B-Cell Lymphoma
Authors: Uddin Shahab , Hussain Azhar R. , Ahmed Maqbool , Bu Rong , Ahmed Saeeda O. , Ajarim Dahish , Al-Dayel Fouad , Bavi Prashant , Al-Kuraya Khawla S.
Published: April 2023

Supplementary Data from Inhibition of Fatty Acid Synthase Suppresses c-Met Receptor Kinase and Induces Apoptosis in Diffuse Large B-Cell Lymphoma
Supplementary Data from SCH 2047069, a Novel Oral Kinesin Spindle Protein Inhibitor, Shows Single-Agent Antitumor Activity and Enhances the Efficacy of Chemotherapeutics
Authors: Basso Andrea D. , Liu Ming , Dai Chaoyang , Gray Kimberly , Nale Lissette , Tevar Seema , Lee Suining , Liang Lianzhu , Ponery Abdul , Yaremko Bohdan , Smith Elizabeth , Tang Huadong , Sheth Payal R. , Siddiqui M. Arshad , Hicklin Daniel J. , Kirschmeier Paul
Published: April 2023

Supplementary Tables 1, 2, and 3 and Supplementary Figures 1 and 2
Supplementary Figure Legends from Administration of PLK-1 small interfering RNA with atelocollagen prevents the growth of liver metastases of lung cancer
Authors: Kawata Eri , Ashihara Eishi , Kimura Shinya , Takenaka Kazumasa , Sato Kiyoshi , Tanaka Ruriko , Yokota Asumi , Kamitsuji Yuri , Takeuchi Miki , Kuroda Junya , Tanaka Fumihiro , Yoshikawa Toshikazu , Maekawa Taira
Published: April 2023

Supplementary Figure Legends from Administration of PLK-1 small interfering RNA with atelocollagen prevents the growth of liver metastases of lung cancer
Supplementary Fig. S1 from Administration of PLK-1 small interfering RNA with atelocollagen prevents the growth of liver metastases of lung cancer
Authors: Kawata Eri , Ashihara Eishi , Kimura Shinya , Takenaka Kazumasa , Sato Kiyoshi , Tanaka Ruriko , Yokota Asumi , Kamitsuji Yuri , Takeuchi Miki , Kuroda Junya , Tanaka Fumihiro , Yoshikawa Toshikazu , Maekawa Taira
Published: April 2023

Supplementary Fig. S1 from Administration of PLK-1 small interfering RNA with atelocollagen prevents the growth of liver metastases of lung cancer
Supplementary Table S2 from Phase I safety, pharmacokinetic, and pharmacogenomic trial of ES-285, a novel marine cytotoxic agent, administered to adult patients with advanced solid tumors
Authors: Baird Richard D. , Kitzen Jos , Clarke Paul A. , Planting Andre , Reade Sarah , Reid Alison , Welsh Lyndsey , López Lázaro Luis , de las Heras Begona , Judson Ian R. , Kaye Stan B. , Eskens Ferry , Workman Paul , deBono Johann S. , Verweij Jaap
Published: April 2023

Supplementary Table S2 from Phase I safety, pharmacokinetic, and pharmacogenomic trial of ES-285, a novel marine cytotoxic agent, administered to adult patients with advanced solid tumors
Supplementary Figure and Table Legends from Synthesis and biological analysis of new curcumin analogues bearing an enhanced potential for the medicinal treatment of cancer
Authors: Ohori Hisatsugu , Yamakoshi Hiroyuki , Tomizawa Masaki , Shibuya Masatoshi , Kakudo Yuichi , Takahashi Atsuko , Takahashi Shin , Kato Satoshi , Suzuki Takao , Ishioka Chikashi , Iwabuchi Yoshiharu , Shibata Hiroyuki
Published: April 2023

Supplementary Figure and Table Legends from Synthesis and biological analysis of new curcumin analogues bearing an enhanced potential for the medicinal treatment of cancer
Supplementary Figure 5 from Synthesis and biological analysis of new curcumin analogues bearing an enhanced potential for the medicinal treatment of cancer
Authors: Ohori Hisatsugu , Yamakoshi Hiroyuki , Tomizawa Masaki , Shibuya Masatoshi , Kakudo Yuichi , Takahashi Atsuko , Takahashi Shin , Kato Satoshi , Suzuki Takao , Ishioka Chikashi , Iwabuchi Yoshiharu , Shibata Hiroyuki
Published: April 2023

Supplementary Figure 5 from Synthesis and biological analysis of new curcumin analogues bearing an enhanced potential for the medicinal treatment of cancer
Supplementary Fig. S2 from Phase I safety, pharmacokinetic, and pharmacogenomic trial of ES-285, a novel marine cytotoxic agent, administered to adult patients with advanced solid tumors
Authors: Baird Richard D. , Kitzen Jos , Clarke Paul A. , Planting Andre , Reade Sarah , Reid Alison , Welsh Lyndsey , López Lázaro Luis , de las Heras Begona , Judson Ian R. , Kaye Stan B. , Eskens Ferry , Workman Paul , deBono Johann S. , Verweij Jaap
Published: April 2023

Supplementary Fig. S2 from Phase I safety, pharmacokinetic, and pharmacogenomic trial of ES-285, a novel marine cytotoxic agent, administered to adult patients with advanced solid tumors
Supplementary Figure 4 from Synthesis and biological analysis of new curcumin analogues bearing an enhanced potential for the medicinal treatment of cancer
Authors: Ohori Hisatsugu , Yamakoshi Hiroyuki , Tomizawa Masaki , Shibuya Masatoshi , Kakudo Yuichi , Takahashi Atsuko , Takahashi Shin , Kato Satoshi , Suzuki Takao , Ishioka Chikashi , Iwabuchi Yoshiharu , Shibata Hiroyuki
Published: April 2023

Supplementary Figure 4 from Synthesis and biological analysis of new curcumin analogues bearing an enhanced potential for the medicinal treatment of cancer
Supplementary Figure Legend from Sensitivity to the Aromatase Inhibitor Letrozole Is Prolonged After a “Break” in Treatment
Authors: Sabnis Gauri , Goloubeva Olga , Gilani Rabia , Macedo Luciana , Brodie Angela
Published: April 2023

Supplementary Figure Legend from Sensitivity to the Aromatase Inhibitor Letrozole Is Prolonged After a “Break” in Treatment
Supplementary Table 2 from Ligand-Specific Antibodies to Insulin-Like Growth Factors Suppress Intestinal Polyp Formation in Apc+/− Mice
Authors: Matsunaka Toshihiro , Miyamoto Shin'ichi , Shitara Kenya , Ochiai Atsushi , Chiba Tsutomu
Published: April 2023

Supplementary Table 2 from Ligand-Specific Antibodies to Insulin-Like Growth Factors Suppress Intestinal Polyp Formation in Apc+/− Mice
Supplementary Tables, 1-5, Figure 1 from Stage 2 Combination Testing of Rapamycin with Cytotoxic Agents by the Pediatric Preclinical Testing Program
Authors: Houghton Peter J. , Morton Christopher L. , Gorlick Richard , Lock Richard B. , Carol Hernan , Reynolds C. Patrick , Kang Min H. , Maris John M. , Keir Stephen T. , Kolb E. Anders , Wu Jianrong , Wozniak Amy W. , Billups Catherine A. , Rubinstein Larry , Smith Malcolm A.
Published: April 2023

Supplementary Tables, 1-5, Figure 1 from Stage 2 Combination Testing of Rapamycin with Cytotoxic Agents by the Pediatric Preclinical Testing Program
Supplementary Figure 1 from Ligand-Specific Antibodies to Insulin-Like Growth Factors Suppress Intestinal Polyp Formation in Apc+/− Mice
Authors: Matsunaka Toshihiro , Miyamoto Shin'ichi , Shitara Kenya , Ochiai Atsushi , Chiba Tsutomu
Published: April 2023

Supplementary Figure 1 from Ligand-Specific Antibodies to Insulin-Like Growth Factors Suppress Intestinal Polyp Formation in Apc+/− Mice
Supplementary Table 1 from PF-03814735, an Orally Bioavailable Small Molecule Aurora Kinase Inhibitor for Cancer Therapy
Authors: Jani Jitesh P. , Arcari Joel , Bernardo Vincent , Bhattacharya Samit K. , Briere David , Cohen Bruce D. , Coleman Kevin , Christensen James G. , Emerson Erling O. , Jakowski Amy , Hook Kenneth , Los Gerrit , Moyer James D. , Pruimboom-Brees Ingrid , Pustilnik Leslie , Rossi Ann Marie , Steyn Stefan J. , Su Chunyan , Tsaparikos Konstantinos , Wishka Donn , Yoon Kwansik , Jakubczak John L.
Published: April 2023

Supplementary Table 1 from PF-03814735, an Orally Bioavailable Small Molecule Aurora Kinase Inhibitor for Cancer Therapy
Supplementary Video 2 from The Dynamin Inhibitors MiTMAB and OcTMAB Induce Cytokinesis Failure and Inhibit Cell Proliferation in Human Cancer Cells
Authors: Joshi Sanket , Perera Swetha , Gilbert Jayne , Smith Charlotte M. , Mariana Anna , Gordon Christopher P. , Sakoff Jennette A. , McCluskey Adam , Robinson Phillip J. , Braithwaite Antony W. , Chircop Megan
Published: April 2023

Supplementary Video 2 from The Dynamin Inhibitors MiTMAB and OcTMAB Induce Cytokinesis Failure and Inhibit Cell Proliferation in Human Cancer Cells
Supplementary Figure Legends from A MicroRNA Screen to Identify Modulators of Sensitivity to BCL2 Inhibitor ABT-263 (Navitoclax)
Authors: Lam Lloyd T. , Lu Xin , Zhang Haichao , Lesniewski Rick , Rosenberg Saul , Semizarov Dimitri
Published: April 2023

Supplementary Figure Legends from A MicroRNA Screen to Identify Modulators of Sensitivity to BCL2 Inhibitor ABT-263 (Navitoclax)
Supplementary Figure 3 from A MicroRNA Screen to Identify Modulators of Sensitivity to BCL2 Inhibitor ABT-263 (Navitoclax)
Authors: Lam Lloyd T. , Lu Xin , Zhang Haichao , Lesniewski Rick , Rosenberg Saul , Semizarov Dimitri
Published: April 2023

Supplementary Figure 3 from A MicroRNA Screen to Identify Modulators of Sensitivity to BCL2 Inhibitor ABT-263 (Navitoclax)
Supplementary Figures from Parthenolide promotes the ubiquitination of MDM2 and activates p53 cellular functions
Authors: Gopal Y.N. Vashisht , Chanchorn Ekkawit , Van Dyke Michael W.
Published: April 2023

Supplementary Figures from Parthenolide promotes the ubiquitination of MDM2 and activates p53 cellular functions
Supplementary Figure 2D-E from A MicroRNA Screen to Identify Modulators of Sensitivity to BCL2 Inhibitor ABT-263 (Navitoclax)
Authors: Lam Lloyd T. , Lu Xin , Zhang Haichao , Lesniewski Rick , Rosenberg Saul , Semizarov Dimitri
Published: April 2023

Supplementary Figure 2D-E from A MicroRNA Screen to Identify Modulators of Sensitivity to BCL2 Inhibitor ABT-263 (Navitoclax)
Supplementary Figure 2A-C from A MicroRNA Screen to Identify Modulators of Sensitivity to BCL2 Inhibitor ABT-263 (Navitoclax)
Authors: Lam Lloyd T. , Lu Xin , Zhang Haichao , Lesniewski Rick , Rosenberg Saul , Semizarov Dimitri
Published: April 2023

Supplementary Figure 2A-C from A MicroRNA Screen to Identify Modulators of Sensitivity to BCL2 Inhibitor ABT-263 (Navitoclax)
Supplementary Data from Correction for chromosome-17 is critical for the determination of true Her-2/neu gene amplification status in breast cancer
Authors: Dal Lago Lissandra , Durbecq Virginie , Desmedt Christine , Salgado Roberto , Verjat Thibault , Lespagnard Laurence , Ma Yan , Veys Isabelle , Di Leo Angelo , Sotiriou Christos , Piccart Martine , Larsimont Denis
Published: April 2023

Supplementary Data from Correction for chromosome-17 is critical for the determination of true Her-2/neu gene amplification status in breast cancer
Supplementary Tables from Simultaneous blockade of the epidermal growth factor receptor/mammalian target of rapamycin pathway by epidermal growth factor receptor inhibitors and rapamycin results in reduced cell growth and survival in biliary tract cancer cells
Authors: Herberger Beata , Berger Walter , Puhalla Harald , Schmid Katharina , Novak Sabine , Brandstetter Anita , Pirker Christine , Gruenberger Thomas , Filipits Martin
Published: April 2023

Supplementary Tables from Simultaneous blockade of the epidermal growth factor receptor/mammalian target of rapamycin pathway by epidermal growth factor receptor inhibitors and rapamycin results in reduced cell growth and survival in biliary tract cancer cells
Supplementary Table S3 from Antixenograft tumor activity of a humanized anti-insulin-like growth factor-I receptor monoclonal antibody is associated with decreased AKT activation and glucose uptake
Authors: Shang Yonglei , Mao Yifan , Batson Jennifer , Scales Suzie J. , Phillips Gail , Lackner Mark R. , Totpal Klara , Williams Simon , Yang Jihong , Tang Zhijun , Modrusan Zora , Tan Christine , Liang Wei-Ching , Tsai Siao Ping , Vanderbilt Alexander , Kozuka Kenji , Hoeflich Klaus , Tien Janet , Ross Sarajane , Li Congfen , Lee Sang Hoon , Song An , Wu Yan , Stephan Jean-Philippe , Ashkenazi Avi , Zha Jiping
Published: April 2023

Supplementary Table S3 from Antixenograft tumor activity of a humanized anti-insulin-like growth factor-I receptor monoclonal antibody is associated with decreased AKT activation and glucose uptake
Supplementary Table S2 from Antixenograft tumor activity of a humanized anti-insulin-like growth factor-I receptor monoclonal antibody is associated with decreased AKT activation and glucose uptake
Authors: Shang Yonglei , Mao Yifan , Batson Jennifer , Scales Suzie J. , Phillips Gail , Lackner Mark R. , Totpal Klara , Williams Simon , Yang Jihong , Tang Zhijun , Modrusan Zora , Tan Christine , Liang Wei-Ching , Tsai Siao Ping , Vanderbilt Alexander , Kozuka Kenji , Hoeflich Klaus , Tien Janet , Ross Sarajane , Li Congfen , Lee Sang Hoon , Song An , Wu Yan , Stephan Jean-Philippe , Ashkenazi Avi , Zha Jiping
Published: April 2023

Supplementary Table S2 from Antixenograft tumor activity of a humanized anti-insulin-like growth factor-I receptor monoclonal antibody is associated with decreased AKT activation and glucose uptake
Supplementary Table S1 from Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin
Authors: Kovalchuk Olga , Filkowski Jody , Meservy James , Ilnytskyy Yaroslav , Tryndyak Volodymyr P. , Chekhun Vasyl' F. , Pogribny Igor P.
Published: April 2023

Supplementary Table S1 from Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin
Supplementary Fig. from Epigenetic reversal of acquired resistance to 5-fluorouracil treatment
Authors: Humeniuk Rita , Mishra Prasun J. , Bertino Joseph R. , Banerjee Debabrata
Published: April 2023

Supplementary Fig. from Epigenetic reversal of acquired resistance to 5-fluorouracil treatment
Supplementary Fig. S3 from Antixenograft tumor activity of a humanized anti-insulin-like growth factor-I receptor monoclonal antibody is associated with decreased AKT activation and glucose uptake
Authors: Shang Yonglei , Mao Yifan , Batson Jennifer , Scales Suzie J. , Phillips Gail , Lackner Mark R. , Totpal Klara , Williams Simon , Yang Jihong , Tang Zhijun , Modrusan Zora , Tan Christine , Liang Wei-Ching , Tsai Siao Ping , Vanderbilt Alexander , Kozuka Kenji , Hoeflich Klaus , Tien Janet , Ross Sarajane , Li Congfen , Lee Sang Hoon , Song An , Wu Yan , Stephan Jean-Philippe , Ashkenazi Avi , Zha Jiping
Published: April 2023

Supplementary Fig. S3 from Antixenograft tumor activity of a humanized anti-insulin-like growth factor-I receptor monoclonal antibody is associated with decreased AKT activation and glucose uptake
Supplementary Fig. S1 from Antixenograft tumor activity of a humanized anti-insulin-like growth factor-I receptor monoclonal antibody is associated with decreased AKT activation and glucose uptake
Authors: Shang Yonglei , Mao Yifan , Batson Jennifer , Scales Suzie J. , Phillips Gail , Lackner Mark R. , Totpal Klara , Williams Simon , Yang Jihong , Tang Zhijun , Modrusan Zora , Tan Christine , Liang Wei-Ching , Tsai Siao Ping , Vanderbilt Alexander , Kozuka Kenji , Hoeflich Klaus , Tien Janet , Ross Sarajane , Li Congfen , Lee Sang Hoon , Song An , Wu Yan , Stephan Jean-Philippe , Ashkenazi Avi , Zha Jiping
Published: April 2023

Supplementary Fig. S1 from Antixenograft tumor activity of a humanized anti-insulin-like growth factor-I receptor monoclonal antibody is associated with decreased AKT activation and glucose uptake
Supplementary Figure 3 from Combination of Two Insulin-Like Growth Factor-I Receptor Inhibitory Antibodies Targeting Distinct Epitopes Leads to an Enhanced Antitumor Response
Authors: Dong Jianying , Demarest Stephen J. , Sereno Arlene , Tamraz Susan , Langley Emma , Doern Adam , Snipas Tracey , Perron Keli , Joseph Ingrid , Glaser Scott M. , Ho Steffan N. , Reff Mitchell E. , Hariharan Kandasamy
Published: April 2023

Supplementary Figure 3 from Combination of Two Insulin-Like Growth Factor-I Receptor Inhibitory Antibodies Targeting Distinct Epitopes Leads to an Enhanced Antitumor Response
Supplementary Table S1 from Hypoxia prevents etoposide-induced DNA damage in cancer cells through a mechanism involving hypoxia-inducible factor 1
Authors: Sullivan Richard , Graham Charles H.
Published: April 2023

Supplementary Table S1 from Hypoxia prevents etoposide-induced DNA damage in cancer cells through a mechanism involving hypoxia-inducible factor 1
Supplementary Figure 1 from Combination of Two Insulin-Like Growth Factor-I Receptor Inhibitory Antibodies Targeting Distinct Epitopes Leads to an Enhanced Antitumor Response
Authors: Dong Jianying , Demarest Stephen J. , Sereno Arlene , Tamraz Susan , Langley Emma , Doern Adam , Snipas Tracey , Perron Keli , Joseph Ingrid , Glaser Scott M. , Ho Steffan N. , Reff Mitchell E. , Hariharan Kandasamy
Published: April 2023

Supplementary Figure 1 from Combination of Two Insulin-Like Growth Factor-I Receptor Inhibitory Antibodies Targeting Distinct Epitopes Leads to an Enhanced Antitumor Response
Supplementary Fig. S4 from Hypoxia prevents etoposide-induced DNA damage in cancer cells through a mechanism involving hypoxia-inducible factor 1
Authors: Sullivan Richard , Graham Charles H.
Published: April 2023

Supplementary Fig. S4 from Hypoxia prevents etoposide-induced DNA damage in cancer cells through a mechanism involving hypoxia-inducible factor 1
Supplementary Fig. S3 from Hypoxia prevents etoposide-induced DNA damage in cancer cells through a mechanism involving hypoxia-inducible factor 1
Authors: Sullivan Richard , Graham Charles H.
Published: April 2023

Supplementary Fig. S3 from Hypoxia prevents etoposide-induced DNA damage in cancer cells through a mechanism involving hypoxia-inducible factor 1
Supplementary Fig. S1 from Targeting homologous recombination using imatinib results in enhanced tumor cell chemosensitivity and radiosensitivity
Authors: Choudhury Ananya , Zhao Helen , Jalali Farid , AL Rashid Shahnaz , Ran Jane , Supiot Stephane , Kiltie Anne E. , Bristow Robert G.
Published: April 2023

Supplementary Fig. S1 from Targeting homologous recombination using imatinib results in enhanced tumor cell chemosensitivity and radiosensitivity
Supplementary Data from Hypoxia prevents etoposide-induced DNA damage in cancer cells through a mechanism involving hypoxia-inducible factor 1
Authors: Sullivan Richard , Graham Charles H.
Published: April 2023

Supplementary Data from Hypoxia prevents etoposide-induced DNA damage in cancer cells through a mechanism involving hypoxia-inducible factor 1
Supplementary Fig. from Identification of novel small-molecule compounds that inhibit the proproliferative Krüppel-like factor 5 in colorectal cancer cells by high-throughput screening
Authors: Bialkowska Agnieszka B. , Du Yuhong , Fu Haian , Yang Vincent W.
Published: April 2023

Supplementary Fig. from Identification of novel small-molecule compounds that inhibit the proproliferative Krüppel-like factor 5 in colorectal cancer cells by high-throughput screening
Supplementary Table 2 from Dihydroartemisinin Induces Apoptosis by a Bak-Dependent Intrinsic Pathway
Authors: Handrick René , Ontikatze Teona , Bauer Kerstin-Daniela , Freier Florian , Rübel Amelie , Dürig Jan , Belka Claus , Jendrossek Verena
Published: April 2023

Supplementary Table 2 from Dihydroartemisinin Induces Apoptosis by a Bak-Dependent Intrinsic Pathway
Supplementary Data from Na,K-ATPase Subunits as Markers for Epithelial-Mesenchymal Transition in Cancer and Fibrosis
Authors: Rajasekaran Sigrid A. , Huynh Thu P. , Wolle Daniel G. , Espineda Cromwell E. , Inge Landon J. , Skay Anna , Lassman Charles , Nicholas Susanne B. , Harper Jeffrey F. , Reeves Anna E. , Ahmed Mansoor M. , Leatherman James M. , Mullin James M. , Rajasekaran Ayyappan K.
Published: April 2023

Supplementary Data from Na,K-ATPase Subunits as Markers for Epithelial-Mesenchymal Transition in Cancer and Fibrosis
Supplementary Figure 2 from Cannabidiol Enhances the Inhibitory Effects of Δ9-Tetrahydrocannabinol on Human Glioblastoma Cell Proliferation and Survival
Authors: Marcu Jahan P. , Christian Rigel T. , Lau Darryl , Zielinski Anne J. , Horowitz Maxx P. , Lee Jasmine , Pakdel Arash , Allison Juanita , Limbad Chandani , Moore Dan H. , Yount Garret L. , Desprez Pierre-Yves , McAllister Sean D.
Published: April 2023

Supplementary Figure 2 from Cannabidiol Enhances the Inhibitory Effects of Δ9-Tetrahydrocannabinol on Human Glioblastoma Cell Proliferation and Survival
Supplementary Table S1 from Glucocorticoid receptor transcriptional isoforms and resistance in multiple myeloma cells
Authors: Sánchez-Vega Beatriz , Krett Nancy , Rosen Steven T. , Gandhi Varsha
Published: April 2023

Supplementary Table S1 from Glucocorticoid receptor transcriptional isoforms and resistance in multiple myeloma cells
Supplementary Figure S1 from Identification of genes and molecular pathways involved in the progression of premalignant oral epithelia
Authors: Banerjee Abhijit G. , Bhattacharyya Indraneel , Vishwanatha Jamboor K.
Published: April 2023

Supplementary Figure S1 from Identification of genes and molecular pathways involved in the progression of premalignant oral epithelia
Supplementary Figure 1, Table 1 from Natural product derivative Bis(4-fluorobenzyl)trisulfide inhibits tumor growth by modification of β-tubulin at Cys 12 and suppression of microtubule dynamics
Authors: Xu Wanhong , Xi Biao , Wu Jieying , An Haoyun , Zhu Jenny , Abassi Yama , Feinstein Stuart C. , Gaylord Michelle , Geng Baoqin , Yan Huifang , Fan Weimin , Sui Meihua , Wang Xiaobo , Xu Xiao
Published: April 2023

Supplementary Figure 1, Table 1 from Natural product derivative Bis(4-fluorobenzyl)trisulfide inhibits tumor growth by modification of β-tubulin at Cys 12 and suppression of microtubule dynamics
Supplementary Data from Triptolide is an inhibitor of RNA polymerase I and II–dependent transcription leading predominantly to down-regulation of short-lived mRNA
Authors: Vispé Stéphane , DeVries Luc , Créancier Laurent , Besse Jérome , Bréand Sophie , Hobson David J. , Svejstrup Jesper Q. , Annereau Jean-Philippe , Cussac Didier , Dumontet Charles , Guilbaud Nicolas , Barret Jean-Marc , Bailly Christian
Published: April 2023

Supplementary Data from Triptolide is an inhibitor of RNA polymerase I and II–dependent transcription leading predominantly to down-regulation of short-lived mRNA
Global analysis of OED genes from Identification of genes and molecular pathways involved in the progression of premalignant oral epithelia
Authors: Banerjee Abhijit G. , Bhattacharyya Indraneel , Vishwanatha Jamboor K.
Published: April 2023

Global analysis of OED genes from Identification of genes and molecular pathways involved in the progression of premalignant oral epithelia
Supplementary Tables 1-4 from Characterization of caspase-dependent and caspase-independent deaths in glioblastoma cells treated with inhibitors of the ubiquitin-proteasome system
Authors: Foti Carmela , Florean Cristina , Pezzutto Antonio , Roncaglia Paola , Tomasella Andrea , Gustincich Stefano , Brancolini Claudio
Published: April 2023

Supplementary Tables 1-4 from Characterization of caspase-dependent and caspase-independent deaths in glioblastoma cells treated with inhibitors of the ubiquitin-proteasome system
Supplementary Figure 1 from A Novel E1B-55kD-Deleted Oncolytic Adenovirus Carrying Mutant KRAS-Regulated hdm2 Transgene Exerts Specific Antitumor Efficacy on Colorectal Cancer Cells
Authors: Liu Chin-Cheng , Liu Jin-Hwang , Wu Suh-Chin , Yen Chueh-Chuan , Chen Wei-Shone , Tsai Ying-Chieh
Published: April 2023

Supplementary Figure 1 from A Novel E1B-55kD-Deleted Oncolytic Adenovirus Carrying Mutant KRAS-Regulated hdm2 Transgene Exerts Specific Antitumor Efficacy on Colorectal Cancer Cells
Supplementary Fig. S3 from MEK/ERK inhibitor U0126 affects in vitro and in vivo growth of embryonal rhabdomyosarcoma
Authors: Marampon Francesco , Bossi Gianluca , Ciccarelli Carmela , Di Rocco Agnese , Sacchi Ada , Pestell Richard G. , Zani Bianca M.
Published: April 2023

Supplementary Fig. S3 from MEK/ERK inhibitor U0126 affects in vitro and in vivo growth of embryonal rhabdomyosarcoma
Supplementary Fig. S1 from Epigenetic mechanisms of irinotecan sensitivity in colorectal cancer cell lines
Authors: Crea Francesco , Giovannetti Elisa , Cortesi Filippo , Mey Valentina , Nannizzi Sara , Gallegos Ruiz Marielle I. , Ricciardi Simona , Del Tacca Mario , Peters Godefridus J. , Danesi Romano
Published: April 2023

Supplementary Fig. S1 from Epigenetic mechanisms of irinotecan sensitivity in colorectal cancer cell lines
Supplementary Figures 1-5 from Enhanced Fas-associated death domain recruitment by histone deacetylase inhibitors is critical for the sensitization of chronic lymphocytic leukemia cells to TRAIL-induced apoptosis
Authors: Inoue Satoshi , Harper Nick , Walewska Renata , Dyer Martin J.S. , Cohen Gerald M.
Published: April 2023

Supplementary Figures 1-5 from Enhanced Fas-associated death domain recruitment by histone deacetylase inhibitors is critical for the sensitization of chronic lymphocytic leukemia cells to TRAIL-induced apoptosis